RIM
SRNE

Rockbridge Investment Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Rockbridge Investment Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100
Closed -$1K – 840
2021
Q3 		$1K Buy
+100
New +$848 ﹤0.01% 733

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Rockbridge Investment Management's SRNE Position: Q4 2021 in Review

Rockbridge Investment Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2021, closing a stake of 100 shares — an estimated $1K sold.

Rockbridge Investment Management first reported a position in SRNE in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 234 funds tracked by Wall St. Rank hold SRNE as of Q4 2021.

  • Rockbridge Investment Management reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • Rockbridge Investment Management sold 100 Sorrento Therapeutics, Inc. shares in Q4 2021, an estimated $1K.
  • Rockbridge Investment Management first reported a position in Sorrento Therapeutics, Inc. in Q3 2021 and held it in 1 quarter.
  • Rockbridge Investment Management's Sorrento Therapeutics, Inc. position peaked at $1K in Q3 2021.
  • 234 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2021.

Based on Rockbridge Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.